[1]吕文超, 崔云甫.胰腺癌流行病学和病因学研究进展[J].世界华人消化杂志, 2011, 19: 2805-2809.
[2]Tanaka T, Sho M, Nishiofuku H, et al. Unresectable pancreatic cancer: arterial embolization to achieve a single blood supply for intraarterial infusion of 5-fluorouracil and full-dose Ⅳ gemcitabine[J]. AJR Am J Roentgenol, 2012, 198: 1445-1452.
[3]Jemal A, Bray F, Center MM, et al. Global cancer statistics[J]. CA Cancer J Clin, 2011, 61: 69-90.
[4]Hu J, Zhao G, Wang HX, et al. A meta-analysis of gemcitabine containing chemotherapy for locally advanced and metastatic pancreatic adenocarcinoma[J]. J Hematol Oncol, 2011, 4: 11.
[5]Triano LR, Chang BW, Saif MW. New developments in the treatment of locally advanced pancreatic cancer. Highlights from the 45th ASCO annual meeting. Orlando, FL, USA. May 29-June 2, 2009[J]. JOP, 2009, 10: 366-372.
[6]Han GH, Yin ZX, Meng XJ, et al. Prospective randomized clinical trial of two drug delivery pathway in the treatment of inoperable advanced pancreatic carcinoma[J]. Chin J Dig Dis, 2006, 7: 45-48.
[7]李槐, 刘德忠, 闫东. 胰腺癌的介入诊疗[J]. 介入放射学杂志, 2008, 17: 381-383.
[8]Kapoor V, Brancatelli G, Federle MP, et al. Multidetector CT arteriography with volumetric three-dimensional rendering to evaluate patients with metastatic colorectal disease for placement of a floxuridine infusion pump[J]. AJR Am J Roentgenol, 2003, 181: 455-463.
[9]马彦寿, 李焕祥, 吕峰泉, 等. 超选择性动脉灌注及栓塞治疗晚期胰头癌[J]. 介入放射学杂志, 2006, 15: 247-248.
[10]刘德忠, 王彬, 闫东, 等. 胰腺癌综合治疗现状及其价值[J]. 介入放射学杂志, 2008, 17: 451-455.
[11]Thomson BN. Pancreatic cancer: current management[J]. Aust Fam Physician, 2006, 35: 212-217.
[12]李伟, 程合, 倪泉兴. 胰腺癌经动脉介入治疗的研究现状[J]. 中国癌症杂志, 2011, 21: 478-483.